US OptionsDetailed Quotes

VRTX241220P530000

Watchlist

61.60
0.000.00%

15min DelayTrading Oct 23 13:49 ET

0.00High0.00Low

Vertex Pharmaceuticals Stock Discussion

Lnova

17 hours ago

$Vertex Pharmaceuticals (VRTX.US)$
nfa

Vertex Stock Plunges 13% Over Pain Drug's Disappointing Study Results

Lnova

17 hours ago

“SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-Opioid Treatments for Pain.
SiteOne’s efforts in non-opioid pain management put it in a unique position relative to Vertex Pharmaceuticals, a major player in the field known for its successful development of cystic fibrosis treatments. Vertex has also been working on non-opioid pain drugs, specifically targeting the NaV1.8 sodium channel, a focal point shared by SiteOne’s lead pro...

SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-Opioid Treatments for Pain

Kevin Travers

Nov 15 15:20

Columns Market Falls to End All-Time High Week | Wall Street Today

In the end, a week that starts with an all-time high for the S&P 500, Dow Jones, and Nasdaq 100, ended with equities lower.
At 4:02 p.m. ET, the three indices closed lower. The $Dow Jones Industrial Average (.DJI.US)$ was off 0.70%, losing 300 points. The $S&P 500 Index (.SPX.US)$ was down 1.32% and the $Nasdaq Composite Index (.IXIC.US)$ was off 2.24%.
MACRO
In macro, core retail sales grew by 0.1% month over month, lower than estimated. ...

Live Stock Financial Podcast. What are you watching on the market?

Kevin Travers

Nov 15 10:12

Columns Market Falls Friday on Earnings | Live Stock

You will not get through the trading day without the news and animal spirits guiding the market. It is finally Friday, November 15th.
My name is Kevin Travers and the market is falling today- here is why.
$Alibaba (BABA.US)$ shares declined after a report from the firm Friday morning that it was facing a consumer demand slump, even though its AI cloud business grew 7% to $4.2B in its second fiscal quarter.
$Applied Materials (AMAT.US)$ fell 8% after r...